Trials / Not Yet Recruiting
Not Yet RecruitingNCT07236502
Moving Foward With Myeloma (MFM)
Moving Forward With Myeloma: A Lifestyle Intervention for Individuals With Multiple Myeloma
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 184 (estimated)
- Sponsor
- Medical College of Wisconsin · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this project is to evaluate the impact of a 16-week lifestyle program that promotes changes in eating and exercise patterns. The main questions the study will answer are: Do improvements in eating and exercise patterns lead to improved physical function, quality of life and blood biomarkers of biologial aging among individuals with multiple myeloma? Participants will complete study activities 3-4 times during the study. 1. In-person assessment to measure physical function, height/weight, body composition, and includes a blood draw 2. Surveys completed online or on paper at home
Detailed description
The study uses a randomized, waitlist control design. Following baseline data collection, participants will be randomized to either the immediate lifestyle intervention group or the waitlist control group. Those who are randomized to the waitlist control group will receive the intervention after the 16-week data collection time point.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Immediate intervention | 16-session intervention that facilitates changes in nutrition and physical activity behaviors to promote improvements in physical function, Patient Reported Outcomes, body composition and general health |
| OTHER | Waitlist | Participants will be asked to maintain their behavior over the 16 week waitlist period and will receive weekly text message relating positive messages unrelated to lifestyle |
Timeline
- Start date
- 2026-01-30
- Primary completion
- 2029-12-15
- Completion
- 2030-02-28
- First posted
- 2025-11-19
- Last updated
- 2026-01-12
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT07236502. Inclusion in this directory is not an endorsement.